Contact
searchSearch
HMP Global

Pediatrics

Featured

Frequently Asked Questions
Pediatrics FAQ: Evidence-Based Answers to Today’s Most-Searched Clinical Questions
01/15/2026
Amanda Balbi
This Pediatrics FAQ page delivers concise, evidence-based answers to the clinical questions pediatricians and healthcare professionals are searching for right now.
This Pediatrics FAQ page delivers concise, evidence-based answers to the clinical questions pediatricians and healthcare professionals are searching for right now.
This Pediatrics FAQ page...
01/15/2026
Pediatrics
children
News
Dupilumab Shows Long-Term Efficacy in Children with Type 2 Asthma, Regardless of Allergy Status
05/28/2025
Riya Gandhi, MA
A long-term study shows that dupilumab significantly reduces asthma exacerbations in children with type 2 asthma, offering sustained benefits for both allergic and non-allergic patients.
A long-term study shows that dupilumab significantly reduces asthma exacerbations in children with type 2 asthma, offering sustained benefits for both allergic and non-allergic patients.
A long-term study shows that...
05/28/2025
The Derm NP/PA
From The Derm NP/PA
Little girl with pigtails discusses family loss with therapist
Feature Story
First Responders Children’s Foundation Helps Families Cope With Loss and Stress
05/23/2025
Carol Brzozowski
The First Responders Children’s Foundation is a national nonprofit serving families of police officers, firefighters, EMTs, paramedics, 9-1-1 dispatchers, and corrections officers nationwide.
The First Responders Children’s Foundation is a national nonprofit serving families of police officers, firefighters, EMTs, paramedics, 9-1-1 dispatchers, and corrections officers nationwide.
The First Responders Children’s...
05/23/2025
EMSWorld
From EMSWorld
Venous Thromboembolism
Venous Thromboembolism in Children: Rivaroxaban Effective and Safe Even With Extended Use
05/23/2025
The research shows that even with long-term treatment of up to one year, there is only a low risk of venous thromboembolism (VTE) recurrence and serious bleeding. Rivaroxaban is the first scientifically proven age-appropriate alternative to...
The research shows that even with long-term treatment of up to one year, there is only a low risk of venous thromboembolism (VTE) recurrence and serious bleeding. Rivaroxaban is the first scientifically proven age-appropriate alternative to...
The research shows that even...
05/23/2025
Cath Lab Digest
From Cath Lab Digest
psoriasis
FDA Alerts
FDA Approves Roflumilast Topical Foam 0.3% for Scalp and Body Plaque Psoriasis in Adults and Adolescents
05/22/2025
Riya Gandhi, MA
Arcutis’ once-daily steroid-free roflumilast foam offers effective, rapid itch relief and full-body clearance for patients 12 and older—expanding treatment options for hard-to-treat psoriasis sites.
Arcutis’ once-daily steroid-free roflumilast foam offers effective, rapid itch relief and full-body clearance for patients 12 and older—expanding treatment options for hard-to-treat psoriasis sites.
Arcutis’ once-daily steroid-free...
05/22/2025
The Dermatologist
From The Dermatologist
woman's hands hold a glass of water and a pill
News
Phase 3 Trial Finds Brexpiprazole Safe and Effective For Short-Term Treatment of Adolescent Schizophrenia
05/16/2025
Maria Mantas
A phase 3 trial found that 2-4mg/day of brexpiprazole was associated with a greater symptom reduction in severity than placebo over a 6-week period in adolescents with schizophrenia.
A phase 3 trial found that 2-4mg/day of brexpiprazole was associated with a greater symptom reduction in severity than placebo over a 6-week period in adolescents with schizophrenia.
A phase 3 trial found that...
05/16/2025
Psych Congress Network
From Psych Congress Network
Robert Bennett, PhD, RN, PPCNP-BC, CPNP-AC
Conference Coverage
Value of Social Support and Symbols of Hope Among Hispanic Adolescent and Young Adult Survivors of Cancer
05/01/2025
Robert Bennett, PhD, PPCNP-BC, CPNP-AC
Robert Bennett, PhD, RN, PPCNP-BC, CPNP-AC, discusses a study aiming to determine symbols of hope as described by Hispanic adolescent and young adult survivors of cancer.
Robert Bennett, PhD, RN, PPCNP-BC, CPNP-AC, discusses a study aiming to determine symbols of hope as described by Hispanic adolescent and young adult survivors of cancer.
Robert Bennett, PhD, RN,...
05/01/2025
Oncology Learning Network NP/PA Institute
From Oncology Learning Network NP/PA Institute
Nnenna Agim
Rapid Refresh
Pediatric Common Infections
04/25/2025
Nnenna Agim, MD
Dr Agim explores common pediatric skin infections caused by bacteria, viruses, fungi, and other microorganisms.
Dr Agim explores common pediatric skin infections caused by bacteria, viruses, fungi, and other microorganisms.
Dr Agim explores common...
04/25/2025
The Derm NP/PA
From The Derm NP/PA
Dr Rakesh Jain
Podcasts
Targeting Hyperactivity and Impulsivity in Adolescents: A Look at Viloxazine ER
04/17/2025
Rakesh Jain, MD, MPH, RD
Join Rakesh Jain, MD, MPH, as he explores the role of viloxazine extended-release (ER) in targeting hyperactivity and impulsivity in adolescents with ADHD.
Join Rakesh Jain, MD, MPH, as he explores the role of viloxazine extended-release (ER) in targeting hyperactivity and impulsivity in adolescents with ADHD.
Join Rakesh Jain, MD, MPH, as he...
04/17/2025
Psych Congress Network
From Psych Congress Network
FDA approval stamp
News
FDA Approves Diazepam Nasal Spray for Children Aged 2 to 5 With Seizure Clusters
04/16/2025
Meagan Thistle
The FDA has expanded approval of immediate-use diazepam nasal spray as an acute treatment of intermittent, stereotypic episodes of frequent seizure activity—also known as seizure clusters or acute repetitive seizures—in pediatric patients...
The FDA has expanded approval of immediate-use diazepam nasal spray as an acute treatment of intermittent, stereotypic episodes of frequent seizure activity—also known as seizure clusters or acute repetitive seizures—in pediatric patients...
The FDA has expanded approval of...
04/16/2025
Neurology
From Neurology
Brittany Gareth Craiglow, MD, FAAD
Videos
Alopecia Areata in Children
04/11/2025
Brittany Craiglow, MD
Explore expert insights on pediatric alopecia areata, including differences in presentation and treatment vs. adults, diagnostic strategies, quality of life considerations, and tailored management approaches to support young patients and...
Explore expert insights on pediatric alopecia areata, including differences in presentation and treatment vs. adults, diagnostic strategies, quality of life considerations, and tailored management approaches to support young patients and...
Explore expert insights on...
04/11/2025
The Dermatologist
From The Dermatologist

Clinical Insights

Robert Bennett, PhD, RN, PPCNP-BC, CPNP-AC
Conference Coverage
Value of Social Support and Symbols of Hope Among Hispanic Adolescent and Young Adult Survivors of Cancer
05/01/2025
Robert Bennett, PhD, PPCNP-BC, CPNP-AC
Robert Bennett, PhD, RN, PPCNP-BC, CPNP-AC, discusses a study aiming to determine symbols of hope as described by Hispanic adolescent and young adult survivors of cancer.
Robert Bennett, PhD, RN, PPCNP-BC, CPNP-AC, discusses a study aiming to determine symbols of hope as described by Hispanic adolescent and young adult survivors of cancer.
Robert Bennett, PhD, RN,...
05/01/2025
Oncology Learning Network NP/PA Institute
Dr Rakesh Jain
Podcasts
Targeting Hyperactivity and Impulsivity in Adolescents: A Look at Viloxazine ER
04/17/2025
Rakesh Jain, MD, MPH, RD
Join Rakesh Jain, MD, MPH, as he explores the role of viloxazine extended-release (ER) in targeting hyperactivity and impulsivity in adolescents with ADHD.
Join Rakesh Jain, MD, MPH, as he explores the role of viloxazine extended-release (ER) in targeting hyperactivity and impulsivity in adolescents with ADHD.
Join Rakesh Jain, MD, MPH, as he...
04/17/2025
Psych Congress Network
Brittany Gareth Craiglow, MD, FAAD
Videos
Alopecia Areata in Children
04/11/2025
Brittany Craiglow, MD
Explore expert insights on pediatric alopecia areata, including differences in presentation and treatment vs. adults, diagnostic strategies, quality of life considerations, and tailored management approaches to support young patients and...
Explore expert insights on pediatric alopecia areata, including differences in presentation and treatment vs. adults, diagnostic strategies, quality of life considerations, and tailored management approaches to support young patients and...
Explore expert insights on...
04/11/2025
The Dermatologist
Pediatric Video Tutorial: Epiglottitis in Children
Videos
Pediatric Video Tutorial: Epiglottitis in Children
03/02/2023
Scott DeBoer, RN, MSN, CPEN, CEN, CCRN, CFRN
Epiglottitis is making a comeback. In this latest pediatric video tutorial, Scott DeBoer of Pedi-Ed-Trics Emergency Medical Solutions covers his top "thou shalt not" commandments.
Epiglottitis is making a comeback. In this latest pediatric video tutorial, Scott DeBoer of Pedi-Ed-Trics Emergency Medical Solutions covers his top "thou shalt not" commandments.
Epiglottitis is making a...
03/02/2023
EMSWorld
Daniel Bagner, PhD.
Videos
Using Telehealth to Deliver Behavioral Interventions for Children
02/07/2023
Daniel Bagner, PhD
In Part 2 of this video Q&A, Dr Bagner details which new avenues he and his colleagues are exploring for the application of behavioral interventions delivered via telehealth.
In Part 2 of this video Q&A, Dr Bagner details which new avenues he and his colleagues are exploring for the application of behavioral interventions delivered via telehealth.
In Part 2 of this video Q&A, Dr...
02/07/2023
Psych Congress Network
Manpreet Singh
Videos
Pediatric ADHD: Proper Diagnosis, Stimulant Therapy
12/16/2021
Manpreet Singh, MD, MS, discusses introducing stimulant therapy for ADHD management, differentiating pediatric ADHD from mood disorders, and gender or ethnic bias during diagnosis.
Manpreet Singh, MD, MS, discusses introducing stimulant therapy for ADHD management, differentiating pediatric ADHD from mood disorders, and gender or ethnic bias during diagnosis.
Manpreet Singh, MD, MS,...
12/16/2021
Psych Congress Network
Manpreet Singh
Videos
Dr Singh Offers "Clinical Clues" to Distinguish Pediatric ADHD From Mood Disorders
12/07/2021
Manpreet K Singh, MD, MS, offers "clinical clues" to clinicians on how to distinguish ADHD from primary mood disorders or other conditions and also discusses comorbid conditions in pediatric ADHD. 
Manpreet K Singh, MD, MS, offers "clinical clues" to clinicians on how to distinguish ADHD from primary mood disorders or other conditions and also discusses comorbid conditions in pediatric ADHD. 
Manpreet K Singh, MD, MS, offers...
12/07/2021
Psych Congress Network
Greg Mattingly, MD
Podcasts
Managing Pediatric ADHD and Stress During the Holidays
12/03/2021
Greg Mattingly, MD
Greg Mattingly, MD, shares tips and advice on managing pediatric ADHD and stress through the holiday season.
Greg Mattingly, MD, shares tips and advice on managing pediatric ADHD and stress through the holiday season.
Greg Mattingly, MD, shares tips...
12/03/2021
Psych Congress Network
Dr Julie Carbray
Videos
Dr Carbray Discusses Pediatric ADHD Symptom Treatment Goals
11/24/2021
Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, discusses her case presentation "Does All ADHD Present the Same?" and the treatment goals of pediatric attention-deficit/hyperactivity disorder (ADHD).   Transcript coming soon.
Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, discusses her case presentation "Does All ADHD Present the Same?" and the treatment goals of pediatric attention-deficit/hyperactivity disorder (ADHD).   Transcript coming soon.
Julie Carbray, PhD, FPMHNP-BC,...
11/24/2021
Psych Congress Network
Dr Malatic
Podcasts
Diagnosing Complex Pediatric Attention-Deficit/Hyperactivity Disorder
09/07/2021
In this podcast, Psych Congress Steering Committee member Vladimir Maletic, MD, MS, discusses the concept of complex attention/deficit-hyperactivity disorder (ADHD), how it is defined, and how clinicians should respond to it.
In this podcast, Psych Congress Steering Committee member Vladimir Maletic, MD, MS, discusses the concept of complex attention/deficit-hyperactivity disorder (ADHD), how it is defined, and how clinicians should respond to it.
In this podcast, Psych...
09/07/2021
Psych Congress Network

Visit Our Other Brands

Consultant360endocrinologyAllergy & Immunology

 

In the News

children
News
Dupilumab Shows Long-Term Efficacy in Children with Type 2 Asthma, Regardless of Allergy Status
05/28/2025
Riya Gandhi, MA
A long-term study shows that dupilumab significantly reduces asthma exacerbations in children with type 2 asthma, offering sustained benefits for both allergic and non-allergic patients.
A long-term study shows that dupilumab significantly reduces asthma exacerbations in children with type 2 asthma, offering sustained benefits for both allergic and non-allergic patients.
A long-term study shows that...
05/28/2025
The Derm NP/PA
Venous Thromboembolism
Venous Thromboembolism in Children: Rivaroxaban Effective and Safe Even With Extended Use
05/23/2025
The research shows that even with long-term treatment of up to one year, there is only a low risk of venous thromboembolism (VTE) recurrence and serious bleeding. Rivaroxaban is the first scientifically proven age-appropriate alternative to...
The research shows that even with long-term treatment of up to one year, there is only a low risk of venous thromboembolism (VTE) recurrence and serious bleeding. Rivaroxaban is the first scientifically proven age-appropriate alternative to...
The research shows that even...
05/23/2025
Cath Lab Digest
woman's hands hold a glass of water and a pill
News
Phase 3 Trial Finds Brexpiprazole Safe and Effective For Short-Term Treatment of Adolescent Schizophrenia
05/16/2025
Maria Mantas
A phase 3 trial found that 2-4mg/day of brexpiprazole was associated with a greater symptom reduction in severity than placebo over a 6-week period in adolescents with schizophrenia.
A phase 3 trial found that 2-4mg/day of brexpiprazole was associated with a greater symptom reduction in severity than placebo over a 6-week period in adolescents with schizophrenia.
A phase 3 trial found that...
05/16/2025
Psych Congress Network
FDA approval stamp
News
FDA Approves Diazepam Nasal Spray for Children Aged 2 to 5 With Seizure Clusters
04/16/2025
Meagan Thistle
The FDA has expanded approval of immediate-use diazepam nasal spray as an acute treatment of intermittent, stereotypic episodes of frequent seizure activity—also known as seizure clusters or acute repetitive seizures—in pediatric patients...
The FDA has expanded approval of immediate-use diazepam nasal spray as an acute treatment of intermittent, stereotypic episodes of frequent seizure activity—also known as seizure clusters or acute repetitive seizures—in pediatric patients...
The FDA has expanded approval of...
04/16/2025
Neurology
AD
News
Dupilumab Effective in Young Children with Eczema, Regardless of Type 2 Inflammatory Comorbidities
04/10/2025
Riya Gandhi, MA
A new study finds that dupilumab significantly improves eczema symptoms in young children, whether they have asthma, allergic rhinitis, or food allergies.
A new study finds that dupilumab significantly improves eczema symptoms in young children, whether they have asthma, allergic rhinitis, or food allergies.
A new study finds that dupilumab...
04/10/2025
The Derm NP/PA
News
Game-based Digital Therapeutic Improves ADHD Symptoms in Children, Adolescents
03/10/2023
Maria Asimopoulos
A game-based digital therapeutic reduced inattention and hyperactivity/impulsivity but was not more effective than medication, findings suggest.
A game-based digital therapeutic reduced inattention and hyperactivity/impulsivity but was not more effective than medication, findings suggest.
A game-based digital therapeutic...
03/10/2023
First Report Managed Care
News
Methylphenidate Does Not Ease Overactivated Visual Perception of Children With ADHD
03/06/2023
Jolynn Tumolo
The contextual visual perception of children with attention-deficit/hyperactivity disorder (ADHD) was not affected by a single dose of methylphenidate.
The contextual visual perception of children with attention-deficit/hyperactivity disorder (ADHD) was not affected by a single dose of methylphenidate.
The contextual visual perception...
03/06/2023
Psych Congress Network
News
Lifelong Marriage and Children Associated With Reduced Dementia Risk
02/26/2023
Evi Arthur
Dementia occurrence was highest in the unmarried and divorced groups.
Dementia occurrence was highest in the unmarried and divorced groups.
Dementia occurrence was highest...
02/26/2023
Psych Congress Network
News
Will RSV Treatment Be Covered Under Vaccines for Children Program?
02/06/2023
Arthur Allen
The Centers for Disease Control and Prevention are assessing whether a monoclonal antibody therapy for respiratory syncytial virus should be eligible for federal funding and distribution.
The Centers for Disease Control and Prevention are assessing whether a monoclonal antibody therapy for respiratory syncytial virus should be eligible for federal funding and distribution.
The Centers for Disease Control...
02/06/2023
Pharmacy Learning Network
News
Antipsychotic Prescribing for Children, Adolescents Doubled Over 20 Years
01/25/2023
Jolynn Tumolo
Over 2 decades, the proportion of antipsychotics prescribed to children and adolescents in England doubled.
Over 2 decades, the proportion of antipsychotics prescribed to children and adolescents in England doubled.
Over 2 decades, the proportion...
01/25/2023
Psych Congress Network

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use